Persistent joint stiffness can make your world feel increasingly small, turning simple walks through your local park into daunting challenges. While joint replacement is a highly successful solution for end-stage arthritis, surgery isn’t always the immediate answer. Let’s look at the biological tools offered by modern orthopedics to bridge the gap between discomfort and the operating room.

The Science of Orthobiologics: PRP and Stem Cell Therapy

Regenerative medicine, or orthobiologics, utilizes the body’s innate healing mechanisms to treat damaged cartilage, tendons, and ligaments. Platelet-Rich Plasma (PRP) involves concentrating platelets from your own blood and injecting them into the joint. These platelets release growth factors that reduce inflammation and improve the biological environment within the knee or hip.

How Regenerative Medicine Reduces Chronic Inflammation to Preserve Cartilage

One of the primary drivers of joint degeneration is chronic inflammation. When a joint is inflamed, it produces enzymes that actively break down cartilage. Orthobiologics act as natural anti-inflammatories. By quieting this "chemical storm," regenerative injections can help preserve the remaining healthy tissue. For patients with mild-to-moderate osteoarthritis, this intervention can significantly extend the lifespan of the natural joint before a replacement becomes necessary.

Improving Functionality Without Hospitalization

One of the greatest benefits of these therapies is that they are performed as outpatient procedures with virtually no downtime. Unlike a major hip or knee replacement, which requires weeks of rehabilitation, PRP allows patients to remain active. By maintaining muscle strength and joint mobility through these biological tune-ups, you keep your body in peak condition. This ensures that if surgery is eventually required years down the road, your recovery will likely be smoother and faster because the surrounding structures remain strong.

Strategic Joint Preservation with Regenerative Medicine

It is important to have realistic expectations. Orthobiologics cannot regrow a completely worn-out joint or "cure" severe, bone-on-bone arthritis. However, for the active individual who wants to maintain their lifestyle while delaying a major procedure, these therapies are a powerful component of a comprehensive orthopedic plan.

As a specialist in minimally invasive hip and knee replacement, my goal is to provide the right treatment at the right time. Whether that involves advanced robotic surgery or the latest in regenerative medicine, the priority is always your mobility and long-term quality of life.

Frequently Asked Questions About PRP & Stem Cell Therapy

Who is a good candidate for PRP?

This treatment is often best suited for patients with mild to moderate joint arthritis or soft-tissue injuries who want to reduce pain, improve function, and delay surgery. Active individuals seeking joint preservation rather than immediate joint replacement may benefit most.

Can PRP eliminate the need for joint replacement?

Orthobiologic treatments cannot reverse advanced, bone-on-bone arthritis. However, it may help reduce inflammation, slow disease progression, and extend the functional lifespan of a joint, sometimes delaying surgery by months or even years.

How long do results typically last?

Response varies by patient, joint condition, and activity level. Many patients experience symptom improvement lasting 6–18 months, with some benefiting from repeat treatments as part of a long-term joint preservation strategy.

Is there downtime after regenerative injections?

PRP is performed on an outpatient basis with minimal downtime. Most patients resume normal daily activities within a day or two, though high-impact activity may be temporarily restricted.

Are these treatments safe?

Because PRP uses the patient’s own biological material, the risk of allergic reaction or rejection is extremely low. When performed by an experienced orthopedic specialist, these procedures have a strong safety profile.

Will insurance cover regenerative medicine treatments?

Many regenerative therapies are not currently covered by insurance. Our team discusses costs, expectations, and alternatives during your consultation so you can make an informed decision.

Hear From Our Patients

Choosing the right orthopedic care is a personal decision, and hearing from others who have been in your position can be helpful. To better understand our approach to personalized, patient-centered orthopedic care, explore some of our patient testimonials.

Reference Links:

• What to Know About Platelet-Rich Plasma (PRP) Treatment - WebMD
• Therapeutic Injections - Cleveland Clinic

AUTHOR: Dr. Nicholas B. Frisch, MD, MBA, FAAOS - Orthopedic Hip & Knee Surgeon
Nicholas B. Frisch, MD, MBA, FAAOS is a board-certified orthopedic surgeon specializing in hip and knee replacement, minimally invasive joint replacement, and complex primary and revision arthroplasty. He practices at Center for Advanced Orthopedics and Sports Medicine in Auburn Hills, Michigan, and serves as Chief of the Department of Surgery at Henry Ford Rochester Hospital.

Credentials & Recognition

Dr. Frisch earned his undergraduate degree from the University of Vermont, his Master's in Medical Science from Loyola University Chicago, and his MD and MBA in Healthcare Management from Tufts University School of Medicine. He received the Norman S. Stern MD|MBA Award for excellence in academics and leadership. Dr. Frisch completed his orthopedic surgery residency at Henry Ford Hospital in Detroit, where he received the 2016 Outstanding Resident Award, and his adult reconstruction fellowship at Rush University Medical Center in Chicago. He is a Fellow of the American Academy of Orthopaedic Surgeons (AAOS) and serves as Health Policy Fellow and Vice Chair of the Young Arthroplasty Group for the American Association of Hip and Knee Surgeons (AAHKS). Dr. Frisch has been recognized as a Top Doctor in Metro Detroit by Hour Detroit and DBusiness magazines from 2022 to present.

Clinical Expertise

Dr. Frisch specializes in minimally invasive hip replacement using anterior and mini-posterior approaches, robotic knee replacement, and outpatient joint replacement procedures. He has published numerous peer-reviewed research articles in leading orthopedic journals including The Journal of Arthroplasty, Arthroscopy Today, and Journal of Surgical Orthopaedic Advances. Dr. Frisch received the 2022 John N. Insall Award from The Knee Society, the 2018 Orthopedics Blue Ribbon Article Award, the 2017 Best Poster in Musculoskeletal Oncology Award at the American Academy of Orthopaedic Surgeons Annual Meeting, and the 2016 Orthopedics Best Clinical Article Award. He serves as Clinical Champion for the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI). Dr. Frisch utilizes efficient pain management pathways and innovative technology to enable rapid recovery and faster return to normal activity for his patients.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. For diagnosis and treatment recommendations, please consult with Dr. Frisch or another qualified orthopedic specialist at FrischOrtho.